10 completed. 10 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 10 |
| Phase 2 | 1 | Completed 1 |
Follow Stage IVA Cervical Cancer: new trials by email Literature Review of Stage IVA Cervical Cancer trials Research Report on Stage IVA Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer Axalimogene filolisbac - Effects of Immunotherapy, Metastatic/Recurrent Cervical Cancer | Phase 1 | Completed | Advaxis, Inc. | 12 | 2015-03-04 | 2024-05-20 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors temsirolimus, vinorelbine ditartrate - Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | Phase 1 | Completed | University of Southern California | 19 | 2010-06-01 | 2016-06-13 |
| Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer fludeoxyglucose F 18, positron emission tomography, computed tomography - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 384 | 2007-09-01 | 2019-07-23 |
| Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer Topotecan Hydrochloride Liposomes, 3-Dimensional Conformal Radiation Therapy, Cisplatin - Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | Phase 1 | Completed | Gynecologic Oncology Group | 11 | 2007-09-01 | 2014-12-31 |
| Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies triapine, laboratory biomarker analysis, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2006-03-01 | 2013-01-11 |
| Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Internal Radiation Therapy, 3-Dimensional Conformal Radiation Therapy, Cetuximab - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 1 | Completed | Gynecologic Oncology Group | 64 | 2005-01-01 | 2014-12-31 |
| Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer Gemcitabine Hydrochloride, Cisplatin, Radiation Therapy - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 1 | Completed | Gynecologic Oncology Group | 13 | 2003-10-01 | 2014-12-25 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction erlotinib hydrochloride, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | National Cancer Institute (NCI) | 75 | 2001-12-01 | 2013-01-16 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) 7-hydroxystaurosporine, irinotecan hydrochloride, diagnostic laboratory biomarker analysis - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Phase 1 | Completed | National Cancer Institute (NCI) | 41 | 2001-12-01 | 2013-09-30 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
Uterine Cervical Neoplasms (10) · Carcinoma, Ovarian Epithelial (5) · Breast Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (4) · Endometrial Neoplasms (4) · Prostatic Neoplasms (4) · Anus Neoplasms (3) · Breast Neoplasms, Male (3) · Carcinoma, Hepatocellular (3) · Colonic Neoplasms (3) · Esophageal Neoplasms (3) · Pancreatic Neoplasms (3) · Rectal Neoplasms (3) · Salivary Gland Neoplasms (3) · Small Cell Lung Carcinoma (3)
Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Genital Diseases (10) · Urogenital Diseases (10) · Genital Diseases, Female (9) · Genital Neoplasms, Female (9) · Neoplasms (9) · Neoplasms by Site (9) · Urogenital Neoplasms (9) · Uterine Cervical Diseases (9) · Uterine Diseases (9) · Uterine Neoplasms (9) · Adnexal Diseases (5) · Bronchial Neoplasms (5) · Carcinoma (5)
Cisplatin (4) · Brachytherapy (3) · Radiotherapy, Conformal (2) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · 7-hydroxystaurosporine (1) · Cetuximab (1) · Erlotinib Hydrochloride (1) · Fluorodeoxyglucose F18 (1) · Gemcitabine (1) · Interleukin-12 (1) · Interleukin-12 Subunit p35 (1) · Irinotecan (1) · Magnetic Resonance Spectroscopy (1) · Radiation (1)
National Cancer Institute (NCI) (5) · Gynecologic Oncology Group (3) · Advaxis, Inc. (1) · University of Southern California (1)
United States (10) · Canada (1) · Japan (1) · South Korea (1)
Peter Rose (2) · Agustin Garcia (1) · Antonius Miller (1) · Charles Kunos (1) · Kathleen Moore (1) · Mostafa Atri (1) · Paula Fracasso (1) · William Carson (1)
U10CA027469 (4), P30CA044579 (1), U01CA062502 (1), U01CA076576 (1), U10CA031946 (1), U10CA180868 (1)